Nicholas Lintzeris

Summary

Country: Australia

Publications

  1. doi Benzodiazepines, methadone and buprenorphine: interactions and clinical management
    Nicholas Lintzeris
    Sydney South West Area Health Service and University of Sydney, Sydney, Australia
    Am J Addict 19:59-72. 2010
  2. ncbi Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
  3. pmc Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, NSW 2052, Australia
    BMC Pharmacol Toxicol 15:17. 2014
  4. doi Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample
    Jessica Belcher
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 33:27-32. 2014
  5. ncbi The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids
    Suzanne Nielsen
    Discipline of Addiction Medicine, University of Sydney, Sydney, NSW, Australia
    Med J Aust 199:696-9. 2013
  6. ncbi Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project
    Erol Digiusto
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    Addict Behav 30:443-56. 2005
  7. ncbi Correlates of pain in an in-treatment sample of opioid-dependent people
    Suzanne Nielsen
    Discipline of Addiction Medicine, The University of Sydney, Sydney, Australia
    Drug Alcohol Rev 32:489-94. 2013
  8. ncbi Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
    David J Allsop
    National Cannabis Prevention and Information Centre, National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, Australia2now with the School of Psychology, University of Sydney, Sydney, Australia
    JAMA Psychiatry 71:281-91. 2014
  9. doi Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings
    Anni Ryan
    South Eastern Sydney Local Health District Drug and Alcohol Service, Sydney, Australia
    Drug Alcohol Rev 33:33-42. 2014
  10. doi The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic
    Parameswaran Ramasamy
    Drug Health Service, Sydney South West Area Health Service, Sydney, Australia
    Addiction 105:329-34. 2010

Collaborators

Detail Information

Publications12

  1. doi Benzodiazepines, methadone and buprenorphine: interactions and clinical management
    Nicholas Lintzeris
    Sydney South West Area Health Service and University of Sydney, Sydney, Australia
    Am J Addict 19:59-72. 2010
    ..An overview of treatment approaches for managing BZD use in this population is presented, including strategies for minimizing abuse and addressing BZD dependence...
  2. ncbi Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
    ..Comparison was made with injecting of two other opioid substitution treatment medications, methadone and buprenorphine (BPN); severe harms have been documented after injection of the latter...
  3. pmc Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, NSW 2052, Australia
    BMC Pharmacol Toxicol 15:17. 2014
    ....
  4. doi Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample
    Jessica Belcher
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 33:27-32. 2014
    ..This study investigated the extent to which an Australian community sample of chronic pain patients prescribed opioids reported supplying their prescribed opioids to others...
  5. ncbi The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids
    Suzanne Nielsen
    Discipline of Addiction Medicine, University of Sydney, Sydney, NSW, Australia
    Med J Aust 199:696-9. 2013
    ..To describe benzodiazepine and prescription opioid use by clients of drug treatment services and the sources of pharmaceuticals they use...
  6. ncbi Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project
    Erol Digiusto
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    Addict Behav 30:443-56. 2005
    ....
  7. ncbi Correlates of pain in an in-treatment sample of opioid-dependent people
    Suzanne Nielsen
    Discipline of Addiction Medicine, The University of Sydney, Sydney, Australia
    Drug Alcohol Rev 32:489-94. 2013
    ..Our hypothesis is that pain may increase aberrant opioid-related behaviours, including illicit substance use, among opioid-dependent people...
  8. ncbi Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
    David J Allsop
    National Cannabis Prevention and Information Centre, National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, Australia2now with the School of Psychology, University of Sydney, Sydney, Australia
    JAMA Psychiatry 71:281-91. 2014
    ..There are no medications approved for treating cannabis dependence or withdrawal. The cannabis extract nabiximols (Sativex), developed as a multiple sclerosis treatment, offers a potential agonist medication for cannabis withdrawal...
  9. doi Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings
    Anni Ryan
    South Eastern Sydney Local Health District Drug and Alcohol Service, Sydney, Australia
    Drug Alcohol Rev 33:33-42. 2014
    ..This study aimed to psychometrically validate the Treatment Outcomes Profile under Australian conditions, examining implementation and feasibility issues in three public opioid treatment program clinics in NSW...
  10. doi The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic
    Parameswaran Ramasamy
    Drug Health Service, Sydney South West Area Health Service, Sydney, Australia
    Addiction 105:329-34. 2010
    ..This study examines the completion rates of a HBV vaccination schedule and seroconversion in a group of patients in methadone maintenance treatment...
  11. ncbi Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions
    Courtney L Breen
    National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Sydney, Australia
    Drug Alcohol Depend 71:49-55. 2003
    ..Buprenorphine is used in the treatment of opioid dependence. Due to its pharmacology, the transfer from methadone to buprenorphine may precipitate withdrawal symptoms...
  12. doi Prescription of heroin for the management of heroin dependence: current status
    Nicholas Lintzeris
    Sydney South West Area Health Service, Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia
    CNS Drugs 23:463-76. 2009
    ....